scPharmaceuticals buy BiotechBee
Start price
29.09.22
/
50%
€6.15
Target price
31.12.24
€8.00
Performance (%)
-23.25%
End price
10.10.22
€4.72
Summary
This prediction ended on 10.10.22 with a price of €4.72. The price of scPharmaceuticals has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.25%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| scPharmaceuticals | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
According to BiotechBee what are the pros and cons of scPharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year